Novosorb Biodegradable Temporizing Matrix (BTM)

Official notice

Authority: The Newcastle Upon Tyne Hospitals NHS Foundation Trust (Central government)

GoodsAward procedure without prior publication of a call for competition

Sectors: Medical Devices & Pharma (33) Delivery: North East (UKC22)

Awarded value£200,000published contract · exc. VAT

Awarded 5 Apr 2024no call for competition

Awarded to MOVIANTO UK LIMITED

What is being bought

Published requirement description

Supply of Novosorb Biodegradable Temporizing Matrix (BTM) via consignment agreement from Polynovo, but delivered by distributor Movianto

CPV: Dressings

The lotProcurement structure

single lot · no lot value published

Lot #1Awarded

Delivery: North East · The Newcastle upon Tyne Hospitals NHSFT - Freeman Hospital

Procedure terms & legal framework

From the official record

Procedure method: Award procedure without prior publication of a call for competition
Legal basis: CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
Procurement category: Goods
Notice status: Awarded without competition
Procurement threshold: Unspecified in notice
Regulatory regime: Standard
Commercial structure: Stand-alone contract (no framework)
Competition type: Direct award (no call for competition)
GPA / WTO covered: Yes (GPA)
Recurring procurement: Unspecified in notice
First published: 22 Apr 2024, 14:44 BST
Last source update: 22 Apr 2024, 14:44 BST
Authority reference: C247669
FTS notice number: 2024/S 000-012982
Classification (CPV): Dressings
Delivery area: North East (UKC22)
Official registry OCID: ocds-h6vhtk-04540d Find a Tender

Why no open competition: The works, supplies or services can be provided only by a particular economic operator due to absence of competition for technical reasons
Published justification: Polynovo is the only supplier of this product and this is the only synthetic dermal template available worldwide. The advantage above other dermal matrices, such as Integra, is that this product is very resistant to infection. Therefore low risk of it getting infected and needing removal. I have not lost a single piece of BTM from infection.<br/><br/>The clinical advantage for burns patients is earlier engagement in physiotherapy, less pain (and painkillers) and better long term scar quality. If the scars are better longterm, they need less scar therapy, less reconstruction and have better quality of life. Other teams are using this for complex wound reconstruction as an alternative to free flap surgery, which can take up to 12 hours. This takes significantly less time to apply, saving theatre time and allowing patients to be discharged earlier from hospital, with less invasive surgery.

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast

Awards 1

Awarded value £200,0001 contract exc. VAT

Bids received 1

Contracts signed 1latest 5 Apr 2024

Awarded to	Value	Date	Status
MOVIANTO UK LIMITED	£200,000 †	—	Awarded

Contracts

Contract 012982-2024-1 · MOVIANTO UK LIMITED
Signed
5 Apr 2024
Value
£200,000
Status
active

Bid statistics published by the authority

Bids	SME	VCSE	Valid bid range
1bids	—	—	—

Contracting authority & participating public bodies

The Newcastle Upon Tyne Hospitals NHS Foundation Trust

Contracting authorityCentral GovernmentBody governed by public lawHealth Regent Point, NEWCASTLE UPON TYNE, North East, NE7 7DNContact name, email, phone

Bidders & participating suppliers

1 commercial party on the notice

Movianto UK LimitedAwarded supplier01243938 1 Progress Park, Milton Keynes, South East, MK43 9SSContact phone

Official documents & specifications

Official links; attachments are not copied

No document links were published on the notice.